Kewaunee Scientific Corporation
42.92-0.02 (-0.05%)
Oct 29, 4:00:02 PM EDT · NasdaqGM · KEQU · USD
Key Stats
Market Cap
123.00MP/E (TTM)
10.39Basic EPS (TTM)
4.13Dividend Yield
0%Recent Filings
10-Q
Q1 FY2026 results
Kewaunee Scientific's Q1 FY2026 sales jumped 47% y/y to $71.1M, fueled by the Nu Aire acquisition closed November 1, 2024 for $53.0M (cash and $23.0M seller notes), while international sales rose 30% y/y on large project deliveries. Gross margin expanded to 29.4% from 25.8%, lifting operating profit 87% y/y to $4.8M, though operating expenses climbed 63% y/y with integration costs; diluted EPS grew 41% y/y to $1.04 on 2,963K shares, reconciling cleanly. Operating cash flow hit $5.8M, yielding $5.0M free cash flow after $0.8M capex (derived), with cash at $19.5M and $20.0M revolver availability against $37.4M term debt and $24.0M seller notes at 8%. Backlog stands firm at $205.0M. Yet supply disruptions from tariffs and geopolitics could snag timelines.
8-K
Board appoints restructuring expert
Kewaunee Scientific appointed J. Jette Campbell to its Board on September 10, 2025, as a Class II director through 2027, leveraging his expertise in financial restructuring and manufacturing from roles at Carl Marks Advisors, PepsiCo, and Frito-Lay. The Board also amended bylaws to set director count between five and nine, enhancing governance flexibility. Campbell joins the Audit Committee, bringing financial literacy to support growth strategies. His addition bolsters oversight amid expansion.
8-K
Q1 sales soar 47% on acquisition boost
Kewaunee Scientific posted Q1 FY2026 sales of $71.1 million, up 46.9% from $48.4 million last year, fueled by Nu Aire integration and easing international delays. Net earnings climbed 41.1% to $3.1 million, with EBITDA surging to $6.3 million. Backlog holds at $205 million. Volatility in project timelines will uneven quarterly results, yet full-year EBITDA should top FY2025.
8-K
Shareholders approve directors, auditors
Kewaunee Scientific Corporation's shareholders at the August 27, 2025 Annual Meeting re-elected Margaret B. Pyle and Donald F. Shaw as Class III directors for three-year terms, with strong support exceeding 85% for each. They ratified Forvis Mazars, LLP as auditors for fiscal 2026 nearly unanimously and approved executive compensation on an advisory basis by 78%. Shareholders favored annual say-on-pay votes, aligning with the board's recommendation. Continuity in governance remains solid.
8-K
Q1 FY2026 earnings date set
Kewaunee Scientific announced on August 27, 2025, plans to release first quarter fiscal 2026 earnings after market close on September 10, 2025, with details posted on its website. This follows the recent Nu Aire acquisition, which bolsters its lab product lineup amid competitive pressures. Investors await metrics on integration benefits. Forward-looking statements highlight risks like supply disruptions.
IPO
Website
Employees
Sector
Industry
BSET
Bassett Furniture Industries, I
14.85-0.26
FGI
FGI Industries Ltd.
5.27+0.26
FLXS
Flexsteel Industries, Inc.
34.86-1.16
HNI
HNI Corporation
41.40-3.30
HOFT
Hooker Furnishings Corporation
8.91+0.13
LEG
Leggett & Platt, Incorporated
10.06-0.53
SCS
Steelcase Inc.
15.96-0.72
SN
SharkNinja, Inc.
95.51-1.65
VIRC
Virco Manufacturing Corporation
7.23-0.17
WHR
Whirlpool Corporation
74.56-3.02